Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs
- PMID: 15595151
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs
Abstract
A study of medical records found that combining the antibiotic erythromycin with strong inhibitors of the liver enzyme CYP3A increased the risk of sudden death from cardiac causes--probably by abnormally raising the blood levels of erythromycin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical